MedPath

Therapeutic effects of Magnesium Sulfate (MgSO4) in acute organophosphate pesticide poisoning

Not Applicable
Conditions
Acute organophosphate pesticide posoning.
Organophosphate and carbamate insecticides
Registration Number
IRCT201104272083N3
Lead Sponsor
Vice-chancellor for research- Mashhad University of Medical Sciences, Mashhad, Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Determined acute moderate to severe organophosphate poisoning ; filling the written informed consent by the patients or close relatives in cases with diminished consciousness.

Exclusion criteria: disinclination to continue ; age of below 10 years or above 60 years old; mild organophosphate poisoning ; history of severe diseases such as heart, lung,renal or hepatic insufficiency, and metabolic diseases ; simultaneous poisoning with other chemicals ; history of epilepsy prior to the poisoning ; passing more than 24 hours after the consumption ; occurring of primary signs and symptoms of Mg poisoning in case group ; ECG changes that require different dose of MgSO4 administration or any other interfering drug

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
RBC Cholinesterase level. Timepoint: prior to the treatment and daily. Method of measurement: blood sample.;ICU admission. Timepoint: after the intervention. Method of measurement: Number of days during ICU admission.;Mechanical ventilation. Timepoint: after the intervention. Method of measurement: number of days within the patient needs mechanical ventilation.;Patients' mortality. Timepoint: after the intervention. Method of measurement: observation.;Post-loading maintenance doses of atropine. Timepoint: at the beginning and at the end of patient's admission. Method of measurement: sum of maintenance of atropine in each day of admission (mg).
Secondary Outcome Measures
NameTimeMethod
Diminished respiratory rate as a complication of MgSO4 infusion. Timepoint: continuously from the beginning of the infusion. Method of measurement: cardiac monitoring.;Diminished deep tendon reflexes as a complication of MgSO4 infusion. Timepoint: each 5 minutes from the beginning of the infusion. Method of measurement: physical examination.;Hypotension as a complication of MgSO4 infusion. Timepoint: continuously from the beginning of the infusion. Method of measurement: cardiac monitoring.
© Copyright 2025. All Rights Reserved by MedPath